Pfizer-BioNTech’s Covid-19 vaccine was 100% efficient at stopping Covid-19 an infection in children aged 12 to fifteen, the corporate introduced Wednesday.
“In contributors aged 12-15 years outdated, [Pfizer’s Covid-19 vaccine] demonstrated 100% efficacy and sturdy antibody responses, exceeding these reported in trial of vaccinated 16-25 12 months outdated contributors in an earlier evaluation and it was properly tolerated,” Pfizer mentioned in a press launch.
Pfizer plans to submit the information to the U.S. Meals and Drug Administration (FDA) and the European Medicines Company (EMA) to be able to request for emergency authorization of the vaccine.
Albert Bourla, Pfizer’s chief govt officer mentioned: “We plan to submit these knowledge to FDA as a proposed modification to our Emergency Use Authorization within the coming weeks and to different regulators around the globe, with the hope of beginning to vaccinate this age group earlier than the beginning of the subsequent faculty 12 months.”
The story is growing. Examine again for particulars.